Vanguard Group Inc Rani Therapeutics Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 709,828 shares of RANI stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
709,828
Previous 709,828
-0.0%
Holding current value
$1.48 Million
Previous $2.7 Million
43.16%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$5.35 Million0.09% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.03 Million1.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$932,8630.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$629,7050.02% of portfolio
-
Stifel Financial Corp St. Louis, MO270KShares$561,1170.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $50.9M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...